Objective: to observe the effect of Feiai Heji(FAHJ) in treating patients with advanced non-small-cell lung cancer(NSCLC). Method: Sixty patients with confirmed diagnosis of advanced NSCLC were selected and randomly divided into two groups:Thirty patients in the control group with chemotherapy alone(NP or GP regimen)

Thirty patients in the treated group were administered with FAHJ and chemotherapy(the regimen was as same as the control group).After 2 cycles

two groups were observed with short-term effect

the main symptom improvement

quality of life

weight changes

adverse reactions

changes in tumor markers and other projects. Result: The improvement of clinical symptoms in the treated group were superior to those in the control group.As well as improved the QOL

decreased marrow suppression

nausea

vomit and other adverse reactions and levels of tumor marks(CEA

CA153).But there was no significant difference in the effective rates and the disease control rates between two groups. Conclusion: FAHJ combined with chemotherapy can be used as an effective

low toxicity approach to treat the advanced non-small cell lung cancer.